| 臺大學術典藏 |
2022-03-22T08:28:24Z |
Electrically tunable plasmonic biosensors based on cavity-coupled structure with graphene
|
Yang C.-S;Chung Y.-C;Cheng Y.-S;Hsu Y.-C;Chen C.-F;Huang N.-N;Chen H.-C;Liu C.-H;Hsu J.-C;Lin Y.-F;Lin T.-R.; Liu C.-H; CHIEN-HAO LIU et al. |
| 臺大學術典藏 |
2022-03-22T08:28:23Z |
Hybrid graphene-based photonic-plasmonic biochemical sensor with a photonic and acoustic cavity structure
|
Yang C.-S;Cheng Y.-S;Hsu Y.-C;Chung Y.-C;Hung J.-T;Liu C.-H;Hsu J.-C;Chen C.-Y;Yang C.-R;Li Y.-T;Huang N.-N;Lin T.-R.; Liu C.-H; CHIEN-HAO LIU et al. |
| 臺大學術典藏 |
2022-03-22T08:28:23Z |
Hybrid graphene-based photonic-plasmonic biochemical sensor with a photonic and acoustic cavity structure
|
Yang C.-S;Cheng Y.-S;Hsu Y.-C;Chung Y.-C;Hung J.-T;Liu C.-H;Hsu J.-C;Chen C.-Y;Yang C.-R;Li Y.-T;Huang N.-N;Lin T.-R.; Liu C.-H; CHIEN-HAO LIU et al. |
| 臺大學術典藏 |
2022-03-22T08:28:11Z |
Prediction of lateral load-displacement curve of reinforced concrete walls with openings under shear failure
|
Tsai R.-J;Hsu Y.-C;Hwang S.-J.; Tsai R.-J; Hsu Y.-C; Hwang S.-J.; SHYH-JIANN HWANG |
| 臺大學術典藏 |
2022-03-22T08:28:11Z |
Prediction of lateral load-displacement curve of reinforced concrete walls with openings under shear failure
|
Tsai R.-J;Hsu Y.-C;Hwang S.-J.; Tsai R.-J; Hsu Y.-C; Hwang S.-J.; SHYH-JIANN HWANG |
| 臺大學術典藏 |
2022-03-22T08:25:38Z |
Electrically tunable plasmonic biosensors based on cavity-coupled structure with graphene
|
Yang C.-S;Chung Y.-C;Cheng Y.-S;Hsu Y.-C;Chen C.-F;Huang N.-N;Chen H.-C;Liu C.-H;Hsu J.-C;Lin Y.-F;Lin T.-R.; Liu C.-H; CHIEN-HAO LIU et al. |
| 臺大學術典藏 |
2022-03-22T08:25:37Z |
Hybrid graphene-based photonic-plasmonic biochemical sensor with a photonic and acoustic cavity structure
|
Yang C.-S;Cheng Y.-S;Hsu Y.-C;Chung Y.-C;Hung J.-T;Liu C.-H;Hsu J.-C;Chen C.-Y;Yang C.-R;Li Y.-T;Huang N.-N;Lin T.-R.; Liu C.-H; CHIEN-HAO LIU et al. |
| 臺大學術典藏 |
2022-03-22T08:25:26Z |
Prediction of lateral load-displacement curve of reinforced concrete walls with openings under shear failure
|
Tsai R.-J;Hsu Y.-C;Hwang S.-J.; Tsai R.-J; Hsu Y.-C; Hwang S.-J.; SHYH-JIANN HWANG |
| 臺大學術典藏 |
2022-03-16T01:32:11Z |
Task-switching performance improvements after Tai Chi Chuan training are associated with greater prefrontal activation in older adults
|
Wu M.-T.; Tang P.-F.; JOSHUA GOH; Chou T.-L.; Chang Y.-K.; Hsu Y.-C.; Chen Y.-J.; Chen N.-C.; Tseng W.-Y.I.; Gau S.S.-F.; Chiu M.-J.; Lan C. |
| 臺大學術典藏 |
2022-03-16T01:32:09Z |
Integrity of the Prefronto-striato-thalamo-prefrontal Loop Predicts Tai Chi Chuan Training Effects on Cognitive Task-switching in Middle-aged and Older Adults
|
Wu M.-T.; Tang P.-F.; Tseng W.-Y.I.; Hsu Y.-C.; Chen Y.-J.; JOSHUA GOH; Chou T.-L.; Chang Y.-K.; Gau S.S.-F.; Lan C. |
| 臺大學術典藏 |
2022-03-14T06:08:28Z |
Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia with kinase fusions in Taiwan
|
Hsu Y.-C.; Yu C.-H.; Chen Y.-M.; Roberts K.G.; Ni Y.-L.; Lin K.-H.; SHIANN-TANG JOU; Lu M.-Y.; Chen S.-H.; Wu K.-H.; Chang H.-H.; Lin D.-T.; Lin S.-W.; Lin Z.-S.; Chiu W.-T.; Chang C.-C.; Ho B.-C.; Mullighan C.G.; Yu S.-L.; Yang Y.-L. |
| 臺大學術典藏 |
2022-03-09T03:12:33Z |
Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations
|
Yuan S.; Yu S.-L.; Chen H.-Y.; Hsu Y.-C.; Su K.-Y.; HUEI-WEN CHEN; Chen C.-Y.; Yu C.-J.; Shih J.-Y.; Chang Y.-L.; Cheng C.-L.; Hsu C.-P.; Hsia J.-Y.; Lin C.-Y.; Wu G.; Liu C.-H.; Wang C.-D.; Yang K.-C.; Chen Y.-W.; Lai Y.-L.; Hsu C.-C.; Lin T.-C.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen J.J.W.; Chang G.-C.; Li K.-C.; Yang P.-C. |
| 臺大學術典藏 |
2022-03-09T03:12:26Z |
R331W missense mutation of oncogene YAP1 is a germline risk allele for lung adenocarcinoma with medical actionability
|
Chen H.-Y.; Yu S.-L.; Ho B.-C.; Su K.-Y.; Hsu Y.-C.; Chang C.-S.; Li Y.-C.; Yang S.-Y.; Hsu P.-Y.; Ho H.; Chang Y.-H.; Chen C.-Y.; Yang H.-I.; Hsu C.-P.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Hsia J.-Y.; Chuang C.-Y.; Yuan S.; Lee M.-H.; Liu C.-H.; Wu G.-I.; Hsiung C.A.; Chen Y.-M.; Wang C.-L.; Huang M.-S.; Yu C.-J.; Chen K.-Y.; Tsai Y.-H.; Su W.-C.; HUEI-WEN CHEN; Chen J.J.W.; Chen C.-J.; Chang G.-C.; Yang P.-C.; Li K.-C. |
| 臺大學術典藏 |
2022-03-09T03:12:19Z |
Landscape of mitochondria genome and clinical outcomes in stage 1 lung adenocarcinoma
|
Raghav L.; Chang Y.-H.; Hsu Y.-C.; Li Y.-C.; Chen C.-Y.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Chuang C.-Y.; Lee M.-H.; Wang C.-L.; HUEI-WEN CHEN; Yu S.-L.; Su S.-F.; Yuan S.-S.; Chen J.J.W.; Ho S.-Y.; Li K.-C.; Yang P.-C.; Chang G.-C.; Chen H.-Y. |
| 臺大學術典藏 |
2022-03-04T05:33:44Z |
Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer
|
Gow C.-H.; Chang Y.-L.; Hsu Y.-C.; Tsai M.-F.; CHEN-TU WU; Yu C.-J.; Yang C.-H.; Lee Y.-C.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2022-03-04T05:33:38Z |
The Motor Protein KIF14 Inhibits Tumor Growth and Cancer Metastasis in Lung Adenocarcinoma
|
Hung P.-F.; Hong T.-M.; Hsu Y.-C.; Chen H.-Y.; Chang Y.-L.; CHEN-TU WU; Chang G.-C.; Jou Y.-S.; Pan S.-H.; Yang P.-C. |
| 臺大學術典藏 |
2022-03-04T03:48:22Z |
Streptococcus agalactiae infective endocarditis with large vegetation in a patient with underlying protein S deficiency
|
Cheng H.-L.; WEI-CHOU LIN; Shih P.-Y.; Huang C.-H.; Hsu Y.-C.; Yie J.-C.; Chen S.-Y.; Lin C.-P. |
| 臺大學術典藏 |
2022-03-04T03:48:22Z |
Serine protease hepsin regulates hepatocyte size and hemodynamic retention of tumor cells by hepatocyte growth factor signaling in mice
|
Hsu Y.-C.; Huang H.-P.; Yu I.-S.; Su K.-Y.; Lin S.-R.; WEI-CHOU LIN; Wu H.-L.; Shi G.-Y.; Tao M.-H.; Kao C.-H.; Wu Y.-M.; Martin P.E.; Lin S.-Y.; Yang P.-C.; Lin S.-W. |
| 臺大學術典藏 |
2022-02-23T02:12:33Z |
Adult progressive intrahepatic cholestasis associated with genetic variations in ATP8B1 and ABCB11
|
Hsu Y.-C.; Chen H.-L.; Wu M.-Z.; Liu Y.-J.; Lee P.-H.; Sheu J.-C.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-02-23T02:12:32Z |
Primary biliary cirrhosis associated with pernicious anemia
|
Chung C.-S.; Hsu Y.-C.; Huang S.-Y.; Jeng Y.-M.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-02-23T02:12:24Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Lu S.-N.; Wang J.-H.; Su C.-W.; Wang T.-E.; Dai C.-Y.; CHIEN-HUNG CHEN; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Lee P.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group |
| 臺大學術典藏 |
2022-02-23T02:12:22Z |
Use of glecaprevir/pibrentasvir in patients with chronic hepatitis c virus infection and severe renal impairment
|
Yap D.Y.H.; Liu K.S.H.; Hsu Y.-C.; Wong G.L.H.; Tsai M.-C.; CHIEN-HUNG CHEN; Hsu C.-S.; Hui Y.T.; Li M.K.K.; Liu C.-H.; Kan Y.-M.; Yu M.-L.; Yuen M.-F. |
| 臺大學術典藏 |
2022-02-23T02:12:18Z |
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B
|
Hsu Y.-C.; Yeh M.-L.; Wong G.L.-H.; CHIEN-HUNG CHEN; Peng C.-Y.; Buti M.; Enomoto M.; Xie Q.; Trinh H.; Preda C.; Liu L.; Cheung K.-S.; Yeo Y.H.; Hoang J.; Huang C.-F.; Riveiro-Barciela M.; Kozuka R.; Istratescu D.; Tsai P.-C.; Accarino E.V.; Lee D.-H.; Wu J.-L.; Huang J.F.; Dai C.-Y.; Cheung R.; Chuang W.-L.; Yuen M.-F.; Wong V.W.-S.; Yu M.-L.; Nguyen M.H. |
| 臺大學術典藏 |
2022-02-22T05:34:26Z |
Adult progressive intrahepatic cholestasis associated with genetic variations in ATP8B1 and ABCB11
|
Hsu Y.-C.; Chen H.-L.; Wu M.-Z.; Liu Y.-J.; Lee P.-H.; Sheu J.-C.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-02-22T05:34:24Z |
Primary biliary cirrhosis associated with pernicious anemia
|
Chung C.-S.; Hsu Y.-C.; Huang S.-Y.; Jeng Y.-M.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-02-22T05:34:15Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Lu S.-N.; Wang J.-H.; Su C.-W.; Wang T.-E.; Dai C.-Y.; CHIEN-HUNG CHEN; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Lee P.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group |
| 臺大學術典藏 |
2022-02-22T05:34:11Z |
Use of glecaprevir/pibrentasvir in patients with chronic hepatitis c virus infection and severe renal impairment
|
Yap D.Y.H.; Liu K.S.H.; Hsu Y.-C.; Wong G.L.H.; Tsai M.-C.; CHIEN-HUNG CHEN; Hsu C.-S.; Hui Y.T.; Li M.K.K.; Liu C.-H.; Kan Y.-M.; Yu M.-L.; Yuen M.-F. |
| 臺大學術典藏 |
2022-02-22T05:34:08Z |
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B
|
Hsu Y.-C.; Yeh M.-L.; Wong G.L.-H.; CHIEN-HUNG CHEN; Peng C.-Y.; Buti M.; Enomoto M.; Xie Q.; Trinh H.; Preda C.; Liu L.; Cheung K.-S.; Yeo Y.H.; Hoang J.; Huang C.-F.; Riveiro-Barciela M.; Kozuka R.; Istratescu D.; Tsai P.-C.; Accarino E.V.; Lee D.-H.; Wu J.-L.; Huang J.F.; Dai C.-Y.; Cheung R.; Chuang W.-L.; Yuen M.-F.; Wong V.W.-S.; Yu M.-L.; Nguyen M.H. |
| 臺大學術典藏 |
2022-02-22T03:37:23Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; PING-HUEI TSENG; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-22T03:37:23Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; PING-HUEI TSENG; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2022-02-22T03:37:18Z |
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
|
Fang Y.-J.; Liou J.-M.; Chen C.-C.; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; PING-HUEI TSENG; Chen C.-C.; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-22T03:37:13Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; PING-HUEI TSENG; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-22T03:37:13Z |
Double-blind, placebo-controlled study with alginate suspension for laryngopharyngeal reflux disease
|
Tseng W.-H.; PING-HUEI TSENG; Wu J.-F.; Hsu Y.-C.; Lee T.-Y.; Ni Y.-H.; Wang H.-P.; Hsiao T.-Y.; Hsu W.-C. |
| 臺大學術典藏 |
2022-02-21T03:52:42Z |
Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations
|
Wu S.-G.; Yang C.-H.; Yu C.-J.; JIH-HSIANG LEE; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2022-02-18T08:46:57Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; CHIEN-CHUAN CHEN; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; CHIEN-CHUAN CHEN; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2022-02-18T08:46:57Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.; CHIEN-CHUAN CHEN; Chen M.-J.; CHIEN-CHUAN CHEN; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:46:53Z |
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
|
Fang Y.-J.; Liou J.-M.; CHIEN-CHUAN CHEN; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; Tseng P.-H.; CHIEN-CHUAN CHEN; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:46:50Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
Liou J.-M.; CHIEN-CHUAN CHEN; Chang C.-Y.; Chen M.-J.; CHIEN-CHUAN CHEN; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S.; the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T08:46:50Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; CHIEN-CHUAN CHEN; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; CHIEN-CHUAN CHEN; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T08:46:45Z |
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
|
Liou J.-M.; CHIEN-CHUAN CHEN; Chang C.-M.; Fang Y.-J.; Bair M.-J.; Chen P.-Y.; Chang C.-Y.; Hsu Y.-C.; Chen M.-J.; CHIEN-CHUAN CHEN; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chen C.-Y.; Hsu W.-F.; Chen Y.-N.; Wu J.-Y.; Lin J.-T.; Lu T.-P.; Chuang E.Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T08:26:10Z |
Endoscopy timing in acute variceal hemorrhage: Perhaps not the sooner the better, but delay not justified
|
Hsu Y.-C.; CHIEH-CHANG CHEN; Wang H.-P. |
| 臺大學術典藏 |
2022-02-18T08:26:10Z |
Early risk stratification with simple clinical parameters for cirrhotic patients with acute upper gastrointestinal bleeding
|
Hsu Y.-C.; Liou J.-M.; Chung C.-S.; Tseng C.-H.; Lin T.-L.; CHIEH-CHANG CHEN; Wu M.-S.; Wang H.-P. |
| 臺大學術典藏 |
2022-02-18T08:26:08Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; CHIEH-CHANG CHEN; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; CHIEH-CHANG CHEN; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2022-02-18T08:26:08Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.; CHIEH-CHANG CHEN; Chen M.-J.; CHIEH-CHANG CHEN; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:26:06Z |
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
|
Fang Y.-J.; Liou J.-M.; CHIEH-CHANG CHEN; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; Tseng P.-H.; CHIEH-CHANG CHEN; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:26:05Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
Liou J.-M.; CHIEH-CHANG CHEN; Chang C.-Y.; Chen M.-J.; CHIEH-CHANG CHEN; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S.; the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T08:26:05Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients
|
Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; Kao J.-H.; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; CHIEH-CHANG CHEN; Fang Y.-J.; Hung H.-W.; Wu C.-Y.; Lin J.-T. |
| 臺大學術典藏 |
2022-02-18T08:26:04Z |
Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy
|
Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; Yang T.-H.; Kao J.-H.; CHIEH-CHANG CHEN; Tseng C.-H.; Tai C.-M.; Lin C.-W.; Wu C.-Y.; Lin J.-T. |
| 臺大學術典藏 |
2022-02-18T08:26:04Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; CHIEH-CHANG CHEN; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; CHIEH-CHANG CHEN; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T08:26:01Z |
Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk
|
Hsu Y.-C.; Nguyen M.H.; Mo L.-R.; Wu M.-S.; Yang T.-H.; CHIEH-CHANG CHEN; Tseng C.-H.; Tai C.-M.; Wu C.-Y.; Lin J.-T.; Tanaka Y.; Chang C.-Y. |
